RECRUITING

Prospective Data Bank Creation to Study Vaginal Conditions

Description

The purpose of this study is to identify and elucidate the pattern and perhaps role of atypical proteins, cytokines and vaginal microbial flora in the pathogenic mechanisms involved in the development of vulvodynia, recurrent fungal and bacterial vaginosis and preterm labor.

Conditions

VulvodyniaMycosesBacterial VaginosisPreterm Labor
Talk to us

Related Conditions:

VulvodyniaMycosesBacterial VaginosisPreterm Labor

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to identify and elucidate the pattern and perhaps role of atypical proteins, cytokines and vaginal microbial flora in the pathogenic mechanisms involved in the development of vulvodynia, recurrent fungal and bacterial vaginosis and preterm labor.

A Prospective Longitudinal Data Bank Creation to Study Vaginal Conditions With a Novel Diagnostic Approach

Prospective Data Bank Creation to Study Vaginal Conditions

Condition
Vulvodynia
Intervention / Treatment

-

Contacts and Locations

Midland

TTUHSC Permian Basin, Midland, Texas, United States, 79701

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * All patients willing to participate, and give informed consent, and
  • * Asymptomatic, non-pregnant, healthy women ages 21 to 75 years with no previous history of any chronic or recurrent vulvovaginal condition who attend our clinical offices for their annual well-woman physical examination.
  • * Non-pregnant women ages 21 to 75 years being evaluated for any gynecological vulvovaginal condition.
  • * Pregnant women ages 21 to 75 years who are both asymptomatic and healthy
  • * Pregnant women ages 21 to 75 who have any gynecological vulvovaginal condition
  • * Asymptomatic patients ages \< 21 or \> 75, or symptomatic patients ages \< 21 or \> 75 years.
  • * Patients diagnosed with cancer or having any medical condition that is not under control including: diabetes mellitus, hypertension, collagen disease, hemoglobinopathy, renal insufficiency, depression, anxiety, psychosis and panic attacks
  • * Patients unable to follow the protocol or unwilling to participate

Ages Eligible for Study

21 Years to 75 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Texas Tech University Health Sciences Center,

Michael L Galloway, DO, PRINCIPAL_INVESTIGATOR, TTUHSC PB

Study Record Dates

2027-12